SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Dynavax Technologies Corporation DVAX NASDAQ

NASDAQ Capital Marke • Healthcare • Drug Manufacturers - Specialty & Generic • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Dynavax Technologies Corporation (DVAX) has 12 identified peers for comparison in the Healthcare sector. Peers include ALKS, AMPH, ANIP, AQST, COLL, DCPH and others.

DVAX has a market capitalization of $1.82B, compared to an average peer market cap of $2.73B.

Peers & Similar Companies — DVAX

$33.22 -1.92% $5.54B

Amphastar Pharmaceuticals, Inc.

$21.68 +1.40% $996.24M

ANI Pharmaceuticals, Inc.

$76.48 -2.31% $1.71B

Aquestive Therapeutics, Inc.

$4.24 +2.17% $421.06M

Collegium Pharmaceutical, Inc.

$34.93 -1.99% $1.11B

Deciphera Pharmaceuticals, Inc.

$25.59 +0.08% $2.21B

DURECT Corporation

$1.91 -1.04% $59.31M

Emergent BioSolutions Inc.

$8.66 +0.12% $448.34M

Eagle Pharmaceuticals, Inc.

$0.09 -75.08% $1.1M

Ironwood Pharmaceuticals, Inc.

$4.37 +8.17% $712.56M

Intra-Cellular Therapies, Inc.

$131.87 0.00% $14.05B

Lantheus Holdings, Inc.

$83.94 +1.45% $5.46B

People Also View

Intra-Cellular Therapies, Inc.

Neurocrine Biosciences, Inc.

Lantheus Holdings, Inc.

Deciphera Pharmaceuticals, Inc.

ANI Pharmaceuticals, Inc.

Collegium Pharmaceutical, Inc.

Pacira BioSciences, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message